99 related articles for article (PubMed ID: 23631169)
1. [Mechanism and risk factors of cardiogenic thromboembolism in patients with atrial fibrillation].
Otsuka T
Nihon Rinsho; 2013 Jan; 71(1):36-40. PubMed ID: 23631169
[TBL] [Abstract][Full Text] [Related]
2. Thrombomodulin and tissue factor pathway inhibitor in endocardium of rapidly paced rat atria.
Yamashita T; Sekiguchi A; Iwasaki YK; Sagara K; Hatano S; Iinuma H; Aizawa T; Fu LT
Circulation; 2003 Nov; 108(20):2450-2. PubMed ID: 14610015
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of thromboembolism in association with atrial fibrillation.
Yamashita T
Circ J; 2007; 71 Suppl A():A40-4. PubMed ID: 17587738
[TBL] [Abstract][Full Text] [Related]
4. Endocardial Changes in Nonvalvular Atrial Fibrillation Without Atrial Thrombus-Thrombomodulin and Tissue Factor Pathway Inhibitor.
An K; Mei J; Zhu J; Tang M
Clin Appl Thromb Hemost; 2018 Oct; 24(7):1148-1152. PubMed ID: 29364003
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin type 1 receptor blockade prevents endocardial dysfunction of rapidly paced atria in rats.
Yamashita T; Sekiguchi A; Kato T; Tsuneda T; Iwasaki YK; Sagara K; Iinuma H; Sawada H; Aizawa T
J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):127-32. PubMed ID: 17907100
[TBL] [Abstract][Full Text] [Related]
6. The endothelium and atrial fibrillation. The prothrombotic state revisited.
Freestone B; Lip GY
Hamostaseologie; 2008 Oct; 28(4):207-12. PubMed ID: 18836646
[TBL] [Abstract][Full Text] [Related]
7. Effects of Aging and Hypertension on the Antithrombotic Function of Atrial Endocardium in Rats.
Iwasaki YK; Sekiguchi A; Makabe R; Kato T; Yamashita T
Int Heart J; 2022; 63(1):141-146. PubMed ID: 35095062
[TBL] [Abstract][Full Text] [Related]
8. Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation.
Greiser M; Neuberger HR; Harks E; El-Armouche A; Boknik P; de Haan S; Verheyen F; Verheule S; Schmitz W; Ravens U; Nattel S; Allessie MA; Dobrev D; Schotten U
J Mol Cell Cardiol; 2009 Mar; 46(3):385-94. PubMed ID: 19100271
[TBL] [Abstract][Full Text] [Related]
9. [Is Atrial Fibrillation a Pre-Thrombotic State?].
Uetsuka Y
Rinsho Byori; 2015 Dec; 63(12):1427-34. PubMed ID: 27089660
[TBL] [Abstract][Full Text] [Related]
10. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
[TBL] [Abstract][Full Text] [Related]
11. Assessment of endothelial (dys)function in atrial fibrillation.
Krishnamoorthy S; Lim SH; Lip GY
Ann Med; 2009; 41(8):576-90. PubMed ID: 19711210
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of CHADS2 score to predict C-reactive protein, left atrial blood stasis, and prognosis in patients with nonrheumatic atrial fibrillation.
Maehama T; Okura H; Imai K; Yamada R; Obase K; Saito K; Hayashida A; Neishi Y; Kawamoto T; Yoshida K
Am J Cardiol; 2010 Aug; 106(4):535-8. PubMed ID: 20691312
[TBL] [Abstract][Full Text] [Related]
13. The prothrombotic state in atrial fibrillation: pathophysiological and management implications.
Khan AA; Lip GYH
Cardiovasc Res; 2019 Jan; 115(1):31-45. PubMed ID: 30388199
[TBL] [Abstract][Full Text] [Related]
14. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
Savelieva I; Bajpai A; Camm AJ
Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
[TBL] [Abstract][Full Text] [Related]
15. A novel approach to left atrial appendage exclusion: the WATCHMAN device.
Gorodnitskiy A; Lucariello RJ; Aizer A; Coppola JT
Cardiol Rev; 2010; 18(5):230-3. PubMed ID: 20699670
[TBL] [Abstract][Full Text] [Related]
16. Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms.
Cove CL; Albert CM; Andreotti F; Badimon L; Van Gelder IC; Hylek EM
Thromb Haemost; 2014 Mar; 111(3):385-91. PubMed ID: 24305974
[TBL] [Abstract][Full Text] [Related]
17. [Clinical risk stratification schemes to predict thromboembolism in patients with atrial fibrillation].
Hirai T; Inoue H
Nihon Rinsho; 2013 Jan; 71(1):105-11. PubMed ID: 23631180
[TBL] [Abstract][Full Text] [Related]
18. Clinical and echocardiographic markers of mortality risk in patients with atrial fibrillation.
Khumri TM; Idupulapati M; Rader VJ; Nayyar S; Stoner CN; Main ML
Am J Cardiol; 2007 Jun; 99(12):1733-6. PubMed ID: 17560884
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation in pigs induces left atrial endocardial transcriptional remodelling.
Cerveró J; Segura V; Macías A; Gavira JJ; Montes R; Hermida J
Thromb Haemost; 2012 Oct; 108(4):742-9. PubMed ID: 22836863
[TBL] [Abstract][Full Text] [Related]
20. Stroke prevention in atrial fibrillation.
Mohammed I; Mohmand-Borkowski A; Burke JF; Kowey PR
J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):73-85. PubMed ID: 22193836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
